2017-06-05 20:30:39 UTC

AGA to Host Webinar on Gastric Cancer Research Funding Opportunities

June 6, 2017

Learn more about opportunities available through the Department of Defense research program.

When researchers think about federal funding for new programs, they most often think about NIH and CDC. However, the Department of Defense (DoD) — through the Congressionally Directed Medical Research Programs (CDMRPs) — offers research funding for many diseases, including gastric cancer.

If you’re unsure how this program works, join Donna Kimbark, PhD, program manager and technical lead for multiple programs and initiatives within DoD’s CDMRPs, for a webinar during which she will review the types of award mechanisms, congressional directives and program cycle. Dr. Kimbark will also provide a step by step explanation of the Peer Reviewed Cancer Research Program (PRCRP) application process. This webinar is co-sponsored by AGA and Debbie’s Dream Foundation: Curing Stomach Cancer.

The webinar will take place on Tuesday, June 13, 2017, from noon – 1 p.m. ET. Register now

Each year, Congress decides, as part of the annual appropriations process, how much funding to allocate to the CDMRPs and which diseases are eligible for research funding. In the recently enacted fiscal year 2017 defense spending bill, $60 million was appropriated for the PRCRP. Among the cancers that would be eligible to compete for this funding is stomach cancer.

More on Gastric Cancer

AGA-Caroline Craig Augustyn & Damian Augustyn Award in Digestive Cancer

May 26, 2017

This grant awards $40,000 for one year to an early career investigator who currently holds a federal or non-federal career development award devoted to conducting research related to digestive cancer.

AGA-R. Robert & Sally Funderburg Research Award in Gastric Cancer

May 22, 2017

This award provides $50,000 per year for two years (totaling $100,000) to an established investigator working on novel approaches in gastric cancer research.

Apply Now

Two New Strategies Emerging to Treat GI Cancers

May 22, 2017

Engineered T cells and immune checkpoint inhibitors show promise for treating GI cancers, according to a well-attended AGA talk at DDW® 2017.